| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 117.69× | 117.69× | 156.78× | 168.89× | 144.62× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.81× | 1.63× | 2.40× | 2.44× | 3.68× | ||
| 0.46× | 0.46× | 0.44× | 0.61× | 0.66× | ||
| 1.72× | 1.72× | −24.81× | 0.08× | 1.49× | ||
| 1.11× | 1.11× | 7.45× | 0.05× | 1.04× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 144.62 | 168.89 | 156.78 | 117.69 | 117.69 | |
| Working Capital Turnover | 3.68 | 2.44 | 2.40 | 1.63 | 1.81 | |
| Asset Turnover | 0.66 | 0.61 | 0.44 | 0.46 | 0.46 | |
| Cash Conversion (CFO/Net Income) | 1.49 | 0.08 | -24.81 | 1.72 | 1.72 | |
| CFO/EBITDA | 1.04 | 0.05 | 7.45 | 1.11 | 1.11 |